Target | Remarks | targetTB pipeline | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
A | B | C | E | F | G | H | I | J | K | ||
I. Cell Wall Biosynthesis | |||||||||||
DdlA (Rv2981c) | Known target of cycloserine [5] | ✔ | ✔ | X | ✔ | ✔ | ✔ | X | |||
EmbA (Rv3794) | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ||||
AftA (Rv3792) | Suggested as an attractive target [76] | ✔ | ✔ | X | ✔ | ✔ | ✔ | X | |||
AftB (Rv3805c) | Suggested as a potential target [77] | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | |||
MurG (Rv2153c) | Suggested as a potential target [78] | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ● | ● | |
II. Lipid Metabolism | |||||||||||
FabH (Rv0533c) | Possible target of thiolactomycin; also suggested as potential target [79, 80] | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ● | ||
FabD (Rv2243) | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ● | |||
AcpM (Rv2244) | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ● | |||
Pks13 (Rv3800c) | Suggested as a promising target against Corynebacterineae [85] | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ● | ||
InhA (Rv1484) | Known target for isoniazid, ethionamide [4] | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ● | ||
PcaA (Rv0470c) | Suggested as a possible target of thiacetazone [86] | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ● | ||
MmaA1 (Rv0645c) | -do- | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ● | ● | |
FadD32 (Rv3801c) | Suggested as a promising target [87] | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ● | ● | |
DesA3 (Rv3229c) | Suggested as a possible target [88] | ✔ | ✔ | ? | ✔ | ✔ | ✔ | X | |||
Fas (Rv2524c) | Possible target of pyrazinamide [89] | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | |||
III. Intermediary Metabolism and Respiration | |||||||||||
LysA (Rv1293) | Lysine auxotroph has vaccine potential [90]; suggested as potential target [91] | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ● | ||
TrpD (Rv2192c) | -do- | ✔ | ✔ | ✔ | X | ✔ | ✔ | X | |||
LeuA (Rv3710) | Suggested as potential target [92] | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ● | ||
DapB (Rv2773c) | Suggested as potential target [93] | ✔ | ✔ | ✔ | X | ✔ | X | X | |||
AroB (Rv2538c) | Shikimate pathway suggested as an attractive target [94] | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ● | ● | |
ArgA (Rv2747) | Essential enzyme catalysing initial step of arginine biosynthesis [95] | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | |||
AlrA (Rv3423c) | Known target of Cycloserine [5] | ✔ | ✔ | X | ✔ | ✔ | ✔ | X | |||
DfrA (Rv2763c) | Important drug target in many pathogens [96]. Suggested as drug target in [96, 97] | ✔ | X | - | ✔ | ✔ | ✔ | X | |||
PanB (Rv2225) | Critical for pantothenic acid synthesis [98] | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ● | ● | |
PanC (Rv3602c) | Critical for pantothenic acid synthesis [98]; suggested as potential target [99] | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ● | ● | |
PanD (Rv3601c) | Critical for pantothenic acid synthesis [98]; suggested as potential target [100] | ✔ | ✔ | X | ✔ | ✔ | ✔ | X | |||
PanK (Rv1092c)/CoaA | Prokaryotic enzymes involved in the synthesis of CoA are good targets [101]; [102] | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | |||
CysH (Rv2392) | Suggested as an attractive drug target [103–106]; CysH is important for Mtb protein during latent infection [58] | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ● | ||
IspD (Rv3582c) | Potential drug target [107] | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ● | ● | |
IspF (Rv3581c) | Potential drug target [107]; attractive target in many pathogens [59] | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ● | ● | |
Icl (Rv0467) | Required for persistence of Mtb in macrophages and mice [36]; suggested as an attractive target [57]. Icl1 and Icl2 are required for fatty acid catabolism and virulence in Mtb [108] | ✔ | ✔ | ✔ | ✔ | ✔ | X | X | |||
AtpE1 (Rv1305) | Inhibited by a diarylquinoline drug R207910 in vitro [109] | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | |||
Cyp121 (Rv2276) | Putative essential gene. Possible role in virulence through studies with ΔAraC/XylS gene regulator mutant (ΔRv1931c) [110]. Induced in isoniazid- and thiolactomycin-treated Mtb [111] | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ● | ||
IV. Information Pathways | |||||||||||
GyrA (Rv0006) | X | ✔ | - | ✔ | ✔ | X | X | ||||
GyrB (Rv0005) | -do- | ✔ | ✔ | X | ✔ | ✔ | X | X | |||
RpoB (Rv0667) | Known target of rifampicin [8] | ✔ | ✔ | ✔ | ✔ | ✔ | X | X | |||
RpsL (Rv0683) | Known target of Streptomycin [114] | ✔ | X | - | ✔ | ✔ | X | X | |||
V. Regulatory proteins | |||||||||||
GlnE (Rv2221c) | Essential for growth of Mtb [115] | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | |||
MtrA (Rv3246c) | Essential for growth of Mtb [116] | X | ✔ | - | ✔ | ✔ | ✔ | X | |||
DevR (Rv3133c) | Two-component system is a novel target in dormant mycobacteria [117]; essential for growth of Mtb under conditions of low oxygen [118] | ✔ | ✔ | ✔ | X | ✔ | ✔ | X | |||
DevS (Rv3132c) | Two-component system is a novel target in dormant mycobacteria [117]; part of the DevR-DevS two-component signal transduction system [118, 119] | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ● | ● | |
PknB (Rv0014c) | Possibly essential for mycobacterial growth and hence possible target [53] | ✔ | ✔ | ✔ | ✔ | X | ✔ | X | |||
PknG (Rv0410c) | Crucial virulence factor [120]; possibly essential for mycobacterial growth and hence possible targets [53] | ✔ | ✔ | X | X | ✔ | ✔ | X | |||
MbtA (Rv2384) | An important adenylation enzyme required for siderophore biosynthesis [121] | ✔ | ✔ | X | ✔ | ✔ | ✔ | X | |||
IdeR (Rv2711) | X | ✔ | - | ✔ | ✔ | X | X |